The two most important things we learned yesterday are
1. ig remains the preferred and first line treatment for cidp.
2. CSL is taking share from takeda evidenced by near double ig revenue growth at csl relative to takers.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$240.21 |
Change
1.500(0.63%) |
Mkt cap ! $116.3B | |||
| Open | High | Low | Value | Volume |
| $238.71 | $241.05 | $237.37 | $567.1M | 2.283M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1607 | $240.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $240.25 | 394 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |